Canada Pension Plan Investment Board Global Blood Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $158,727 - $334,013	4,899 Added 5.89%	88,100 $6 Million
Q2 2022 Aug 12, 2022	BUY	$22.3 - $37.39 $1.82 Million - $3.05 Million	81,600 Added 5096.81%	83,201 $2.66 Million
Q1 2022 May 13, 2022	SELL	$25.68 - $35.59 $69,027 - $95,665	-2,688 Reduced 62.67%	1,601 $55,000
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $101,218 - $163,656	-4,065 Reduced 48.66%	4,289 $126,000
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $212,859 - $311,938	8,354 New	8,354 $213,000
Q4 2020 Feb 17, 2021	SELL	$37.65 - $63.77 $28,425 - $48,146	-755 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $79,509 - $112,256	-1,507 Reduced 66.62%	755 $42,000
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $109,739 - $184,258	2,252 Added 22520.0%	2,262 $143,000
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $417 - $872	10 New	10 $1,000
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $310,394 - $555,993	-6,792 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$45.35 - $57.91 $308,017 - $393,324	6,792 New	6,792 $330,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.